Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10637/9746Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.creator | Pastor, Myriam | - |
| dc.creator | Fernández Calle, Rosalía | - |
| dc.creator | Di Geronimo Quintero, Bruno | - |
| dc.creator | Vicente Rodríguez, Marta | - |
| dc.creator | Zapico Rodríguez, José María | - |
| dc.creator | Gramage Caro, Esther | - |
| dc.creator | Coderch Boué, Claire | - |
| dc.creator | Pérez García, Carmen | - |
| dc.creator | Lasek, Amy W. | - |
| dc.creator | Puchades-Carrasco, Leonor | - |
| dc.creator | Pineda-Lucena, Antonio | - |
| dc.creator | Pascual-Teresa Fernández, Beatriz de | - |
| dc.creator | Herradón Gil-Gallardo, Gonzalo | - |
| dc.creator | Ramos González, Ana | - |
| dc.date | 2018 | es |
| dc.date.accessioned | 2018-11-14T05:00:29Z | - |
| dc.date.available | 2018-11-14T05:00:29Z | - |
| dc.date.issued | 2018-01-20 | - |
| dc.identifier | 000000705403 | es |
| dc.identifier.citation | Pastor M, Fernández-Calle R, Di Geronimo B, Vicente-Rodríguez M, Zapico JM, Gramage E, et al. Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. Vol. 144, European Journal of Medicinal Chemistry. 2018. p. 318-29 | - |
| dc.identifier.issn | 0223-5234 | - |
| dc.identifier.uri | http://hdl.handle.net/10637/9746 | - |
| dc.format | application/pdf | es |
| dc.language.iso | en | es |
| dc.publisher | Elsevier | - |
| dc.relation | This work was supported by Spanish MSSSI (PNSD2015I001), MINECO (CTQ2014-52604-R and SAF2014-53977-R) and the United States National Institute on Alcohol Abuse and Alcoholism (NIAAA, INIA consortium grant AA020912 to A.W.L.) | en |
| dc.relation.ispartof | European Journal of Medicinal Chemistry | - |
| dc.relation.ispartof | European Journal of Medicinal Chemistry | - |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | - |
| dc.subject | PTPRZ1inhibitors | en_EN |
| dc.subject | Pleiotrophin | en_EN |
| dc.subject | Neurogenerative diseases | en_EN |
| dc.title | Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. | en_EN |
| dc.type | Artículo | es |
| europeana.dataProvider | UNIVERSIDAD SAN PABLO CEU | - |
| europeana.isShownAt | http://hdl.handle.net/10637/9746 | - |
| europeana.object | http://repositorioinstitucional.ceu.es/visor/libros/705403/thumb_europeana/705403.jpg | - |
| europeana.provider | Hispana | - |
| europeana.rights | http://creativecommons.org/publicdomain/zero/1.0/ | - |
| europeana.type | TEXT | - |
| dc.identifier.doi | 10.1016/j.ejmech.2017.11.080 | - |
| dc.centro | Universidad San Pablo-CEU | - |
| Aparece en las colecciones: | Facultad de Farmacia | |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.